Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation

Olmesartan medoxomil (OLM) is a first-line antihypertensive drug with low oral bioavailability (28.6%). This study aimed to develop oleogel formulations to decrease OLM side effects and boost its therapeutic efficacy and bioavailability. OLM oleogel formulations were composed of Tween 20, Aerosil 20...

Full description

Saved in:
Bibliographic Details
Main Authors: Rania Moataz El-Dahmy (Author), Ibrahim Elsayed (Author), Jihan Hussein (Author), Mohammad Althubiti (Author), Riyad A. Almaimani (Author), Mahmoud Zaki El-Readi (Author), Marawan A. Elbaset (Author), Bassant M. M. Ibrahim (Author)
Format: Book
Published: MDPI AG, 2023-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items